Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 6, 2019

View Archived Issues

ADC traffic rules revealed

Dystrophy mutation protects cells from HIV infection

An organoid model for prenatal brain development

Potent AXL kinase inhibitor with promising in vitro and in vivo biological activity

CAD-1883 demonstrates promising safety in phase I study

Circulating galectin-1 as a predictive biomarker of CAD and MACE in patients with stable angina

FDA grants IND approval for HH-2710

Patient enrollment ongoing in phase I study of Debio-0123

Phase III CheckMate-548 study does not meet one of its primary endpoints

Bristol-Myers Squibb describes preclinical profile of apelin receptor agonist BMS-986224

New AAV gene therapy for mucopolysaccharidosis IVA

Acesion presents data on the selective negative allosteric SK channel modulator AP-30663

Zika vaccine averts dengue cross-reactive antibody responses

Discovery of indazole/indole derivatives acting as glucagon receptor antagonists

A novel preclinical model of cocaine and alcohol coabuse

Medshine Discovery divulges FGFR inhibitors

Merck & Co. describes HIV integrase inhibitors

European Commission approves Tecentriq for extensive-stage SCLC and non-squamous NSCLC

Sinovent presents new E-NPP 2 inhibitors

Adlai Nortye discloses adenosine A2A and/or A2B receptor antagonists

Universite de Liege discovers new antibacterials

European Commission approves Lonsurf for metastatic gastric cancer

China's NMPA approves Focus V for third-line treatment of SCLC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...